Illumina Inc/ US4523271090 /
2024-09-24 4:24:21 PM | Chg. -0.1900 | Volume | Bid2024-09-24 | Ask2024-09-24 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
129.9100USD | -0.15% | 93,763 Turnover: 8.34 mill. |
129.8000Bid Size: 200 | 130.0200Ask Size: 400 | 20.79 bill.USD | - | - |
GlobeNewswire
08-01
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire
07-29
Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactiv...
GlobeNewswire
07-23
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
GlobeNewswire
07-09
Paragon Genomics Partners with Biosecure ID to Expand Access to CleanPlex® Technology in the UK and ...
GlobeNewswire
06-20
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
GlobeNewswire
06-03
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire
05-29
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire
05-09
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
03-04
Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Scre...
GlobeNewswire
02-27
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term S...
GlobeNewswire
01-09
DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class...
GlobeNewswire
01-09
ILMN DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Lo...
GlobeNewswire
01-08
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. (ILMN) Investors of a Class Action Lawsu...
Newsfile Corp
01-06
ILMN DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel...